US Stock MarketDetailed Quotes

RVNC Revance Therapeutics(Delisted)

Watchlist
  • 3.650
  • 0.0000.00%
Close Feb 5 16:00 ET
381.02MMarket Cap-1.90P/E (TTM)

Revance Therapeutics(Delisted) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Revance Therapeutics(Delisted) Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q359.879M / 68.175M--
Aug 8, 20242024/Q265.389M / 66.290M--
May 9, 20242024/Q151.936M / 56.658M--
Feb 28, 20242023/Q469.799M / 62.098M--
Nov 8, 20232023/Q356.776M / 58.742M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q359.879M / 68.175M--
Aug 8, 20242024/Q265.389M / 66.290M--
May 9, 20242024/Q151.936M / 56.658M--
Feb 28, 20242023/Q469.799M / 62.098M--
Nov 8, 20232023/Q356.776M / 58.742M--

Unlock Free Earnings Estimates

Revance Therapeutics(Delisted) Earnings Reports

  • Revance Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:26 ET

  • Revance Therapeutics | 8-K: Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update

    Nov 7, 2024 16:21 ET

  • Revance Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:40 ET

  • Revance Therapeutics | 8-K: Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update

    Aug 8, 2024 16:10 ET

    • Read more

    Trending Stocks

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    WANDA BEARING
    920002
    +30.00%
    WINDA
    873001
    +29.99%
    SANWEI CO.,LTD.
    831834
    +29.78%
    4
    SUZHOUBEARING
    430418
    +22.62%
    5
    JUNCHUANG TECH
    833533
    +22.38%
    Log In for the Full List
    Unlock Now
    Investment Course
    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
    Discussing
    FOMC leaves rates unchanged, how will you adjust your portfolio?
    FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
    FOMC Press Conference, January 29, 2025